{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T19:09:16Z","timestamp":1780600156927,"version":"3.54.1"},"reference-count":163,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T00:00:00Z","timestamp":1711152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T00:00:00Z","timestamp":1711152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s11033-024-09384-x","type":"journal-article","created":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T11:03:04Z","timestamp":1711191784000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Exosomes in renal cell carcinoma: challenges and opportunities"],"prefix":"10.1007","volume":"51","author":[{"given":"Mahan","family":"Mohammadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantea","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehran","family":"pournazari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houshang","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,23]]},"reference":[{"issue":"24","key":"9384_CR1","doi-asserted-by":"crossref","first-page":"e2103240118","DOI":"10.1073\/pnas.2103240118","volume":"118","author":"Y Zhang","year":"2021","unstructured":"Zhang Y et al (2021) Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response. Proc Natl Acad Sci 118(24):e2103240118","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"9384_CR2","doi-asserted-by":"crossref","first-page":"602","DOI":"10.3390\/cancers12030602","volume":"12","author":"M Kim","year":"2020","unstructured":"Kim M et al (2020) Comprehensive immunoprofiles of renal cell carcinoma subtypes. Cancers 12(3):602","journal-title":"Cancers"},{"issue":"10246","key":"9384_CR3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0140-6736(20)30540-7","volume":"396","author":"J Malyszko","year":"2020","unstructured":"Malyszko J et al (2020) The link between kidney disease and cancer: complications and treatment. Lancet 396(10246):277\u2013287","journal-title":"Lancet"},{"issue":"5","key":"9384_CR4","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","volume":"82","author":"L Bukavina","year":"2022","unstructured":"Bukavina L et al (2022) Epidemiology of renal cell carcinoma: 2022 update. Eur Urol 82(5):529\u2013542","journal-title":"Eur Urol"},{"issue":"24","key":"9384_CR5","doi-asserted-by":"crossref","first-page":"6230","DOI":"10.3390\/cancers14246230","volume":"14","author":"M Larroquette","year":"2022","unstructured":"Larroquette M et al (2022) Therapeutic management of metastatic Clear Cell Renal Cell Carcinoma: A Revolution in every decade. Cancers 14(24):6230","journal-title":"Cancers"},{"issue":"23","key":"9384_CR6","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.3390\/cancers13235981","volume":"13","author":"P\u00c1 Ballesteros","year":"2021","unstructured":"Ballesteros P\u00c1 et al (2021) Molecular mechanisms of resistance to immunotherapy and antiangiogenic treatments in clear cell renal cell carcinoma. Cancers 13(23):5981","journal-title":"Cancers"},{"issue":"5","key":"9384_CR7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41581-021-00394-7","volume":"17","author":"H Scholz","year":"2021","unstructured":"Scholz H et al (2021) Kidney physiology and susceptibility to acute kidney injury: implications for renoprotection. Nat Rev Nephrol 17(5):335\u2013349","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"9384_CR8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000514550","volume":"52","author":"JS Thurlow","year":"2021","unstructured":"Thurlow JS et al (2021) Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy. Am J Nephrol 52(2):98\u2013107","journal-title":"Am J Nephrol"},{"key":"9384_CR9","unstructured":"Jalali F, Nassiri A, Hakemi MS (2021) Awareness and knowledge about kidney transplantation: a reflection on the current state among Iranian patients with end-stage renal disease (ESRD) treated by Dialysis. Iran J Kidney Dis, 15(6)"},{"key":"9384_CR10","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3389\/fpsyt.2020.00106","volume":"11","author":"C De Pasquale","year":"2020","unstructured":"De Pasquale C et al (2020) Psychological and psychopathological aspects of kidney transplantation: a systematic review. Front Psychiatry 11:106","journal-title":"Front Psychiatry"},{"key":"9384_CR11","first-page":"s03","volume":"66","author":"A Ammirati","year":"2020","unstructured":"Ammirati A (2020) Chronic Kidney Disease 66:s03\u2013s09","journal-title":"Chronic Kidney Disease"},{"issue":"3","key":"9384_CR12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.14740\/wjon1279","volume":"11","author":"SA Padala","year":"2020","unstructured":"Padala SA et al (2020) Epidemiology of renal cell carcinoma. World J Oncol 11(3):79\u201387","journal-title":"World J Oncol"},{"key":"9384_CR13","doi-asserted-by":"crossref","unstructured":"Ljungberg B et al (2022) European Association of Urology guidelines on renal cell carcinoma: the 2022 update European urology","DOI":"10.1016\/j.eururo.2022.03.006"},{"key":"9384_CR14","doi-asserted-by":"crossref","first-page":"102882","DOI":"10.1016\/j.critrevonc.2020.102882","volume":"147","author":"E Rassy","year":"2020","unstructured":"Rassy E et al (2020) New rising entities in cancer of unknown primary: is there a real therapeutic benefit? Crit Rev Oncol\/Hematol 147:102882","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"9384_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-019-1085-0","volume":"19","author":"J Li","year":"2020","unstructured":"Li J et al (2020) CircTLK1 promotes the proliferation and metastasis of renal cell carcinoma by sponging miR-136-5p. Mol Cancer 19:1\u201317","journal-title":"Mol Cancer"},{"issue":"3","key":"9384_CR16","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/JU.0000000000000326","volume":"203","author":"WC Huang","year":"2020","unstructured":"Huang WC et al (2020) Chronic kidney disease and kidney cancer surgery: new perspectives. J Urol 203(3):475\u2013485","journal-title":"J Urol"},{"issue":"12","key":"9384_CR17","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/s41581-020-0316-3","volume":"16","author":"CM D\u00edaz-Montero","year":"2020","unstructured":"D\u00edaz-Montero CM, Rini BI, Finke JH (2020) The immunology of renal cell carcinoma. Nat Rev Nephrol 16(12):721\u2013735","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"9384_CR18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1470-2045(22)00793-8","volume":"24","author":"JE Brown","year":"2023","unstructured":"Brown JE et al (2023) Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2\/3 trial. Lancet Oncol 24(3):213\u2013227","journal-title":"Lancet Oncol"},{"issue":"2","key":"9384_CR19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/diseases11020076","volume":"11","author":"M Savaliya","year":"2023","unstructured":"Savaliya M et al (2023) Posterior reversible Encephalopathy Syndrome after Pazopanib Therapy. Diseases 11(2):76","journal-title":"Diseases"},{"issue":"2","key":"9384_CR20","doi-asserted-by":"crossref","first-page":"138","DOI":"10.31486\/toj.18.0015","volume":"19","author":"H Kamli","year":"2019","unstructured":"Kamli H, Li L, Gobe GC (2019) Limitations to the therapeutic potential of tyrosine kinase inhibitors and alternative therapies for kidney cancer. Ochsner J 19(2):138\u2013151","journal-title":"Ochsner J"},{"issue":"4","key":"9384_CR21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41571-020-00455-z","volume":"18","author":"DA Braun","year":"2021","unstructured":"Braun DA et al (2021) Beyond conventional immune-checkpoint inhibition\u2014novel immunotherapies for renal cell carcinoma. Nat Reviews Clin Oncol 18(4):199\u2013214","journal-title":"Nat Reviews Clin Oncol"},{"key":"9384_CR22","doi-asserted-by":"crossref","unstructured":"Mierzejewski B et al (2020) Human and mouse skeletal muscle stem and progenitor cells in health and disease. Seminars in cell & developmental biology. Elsevier","DOI":"10.1016\/j.semcdb.2020.01.004"},{"key":"9384_CR23","doi-asserted-by":"crossref","unstructured":"Rajabzadeh N, Fathi E, Farahzadi R (2019) Stem cell-based regenerative medicine. Stem cell Invest, 6","DOI":"10.21037\/sci.2019.06.04"},{"issue":"1","key":"9384_CR24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3390\/pharmaceutics14010011","volume":"14","author":"ML Franco","year":"2021","unstructured":"Franco ML, Beyerstedt S, Rangel \u00c9B (2021) Klotho and mesenchymal stem cells: a review on cell and gene therapy for chronic kidney disease and acute kidney disease. Pharmaceutics 14(1):11","journal-title":"Pharmaceutics"},{"issue":"8","key":"9384_CR25","first-page":"999","volume":"23","author":"S Changizi-Ashtiyani","year":"2020","unstructured":"Changizi-Ashtiyani S et al (2020) The effect of adipose-derived mesenchymal stem cells on renal function and histopathology in a rat model of ischemia-reperfusion induced acute kidney injury. Iran J Basic Med Sci 23(8):999","journal-title":"Iran J Basic Med Sci"},{"issue":"1","key":"9384_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-019-1471-y","volume":"11","author":"D Liu","year":"2020","unstructured":"Liu D et al (2020) Stem cells: a potential treatment option for kidney diseases. Stem Cell Res Ther 11(1):1\u201320","journal-title":"Stem Cell Res Ther"},{"key":"9384_CR27","unstructured":"Changizi-Ashtiyani S et al (2020) The effect of adipose-derived mesenchymal stem cells on renal function and histopathology in a rat model of ischemia-reperfusion induced acute kidney injury. 23(8):999"},{"key":"9384_CR28","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1007\/s00018-020-03454-6","volume":"77","author":"X-L Fan","year":"2020","unstructured":"Fan X-L et al (2020) Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy. Cell Mol Life Sci 77:2771\u20132794","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"9384_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-022-03220-4","volume":"14","author":"Z Fu","year":"2023","unstructured":"Fu Z et al (2023) Optimization strategies of mesenchymal stem cell-based therapy for acute kidney injury. Stem Cell Res Ther 14(1):1\u201316","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"9384_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-020-02006-w","volume":"12","author":"S Li","year":"2021","unstructured":"Li S et al (2021) Enhanced renoprotective effect of GDNF-modified adipose-derived mesenchymal stem cells on renal interstitial fibrosis. Stem Cell Res Ther 12(1):1\u201317","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"9384_CR31","first-page":"380","volume":"13","author":"L Hafazeh","year":"2019","unstructured":"Hafazeh L et al (2019) Stem cell therapy ameliorates ischemia-reperfusion induced kidney injury after 24 hours reperfusion. Iran J Kidney Dis 13(6):380","journal-title":"Iran J Kidney Dis"},{"key":"9384_CR32","doi-asserted-by":"crossref","unstructured":"Bochon B et al (2019) Mesenchymal stem cells\u2014potential applications in kidney diseases. 20(10):2462","DOI":"10.3390\/ijms20102462"},{"issue":"1","key":"9384_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-021-02402-z","volume":"22","author":"BM Hussen","year":"2022","unstructured":"Hussen BM et al (2022) Strategies to overcome the main challenges of the use of exosomes as drug carrier for cancer therapy. Cancer Cell Int 22(1):1\u201323","journal-title":"Cancer Cell Int"},{"issue":"18","key":"9384_CR34","doi-asserted-by":"crossref","first-page":"6466","DOI":"10.3390\/ijms21186466","volume":"21","author":"K Sidhom","year":"2020","unstructured":"Sidhom K, Obi PO, Saleem A (2020) A review of exosomal isolation methods: is size exclusion chromatography the best option? Int J Mol Sci 21(18):6466","journal-title":"Int J Mol Sci"},{"key":"9384_CR35","doi-asserted-by":"crossref","first-page":"114131","DOI":"10.1016\/j.biopha.2022.114131","volume":"158","author":"AE Altyar","year":"2023","unstructured":"Altyar AE et al (2023) Future regenerative medicine developments and their therapeutic applications. Biomed Pharmacother 158:114131","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"9384_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-021-00730-1","volume":"19","author":"S Gurung","year":"2021","unstructured":"Gurung S et al (2021) The exosome journey: from biogenesis to uptake and intracellular signalling. Cell Communication Signal 19(1):1\u201319","journal-title":"Cell Communication Signal"},{"key":"9384_CR37","doi-asserted-by":"crossref","unstructured":"Tschuschke M et al (2020) Inclusion biogenesis, methods of isolation and clinical application of human cellular exosomes. 9(2):436","DOI":"10.3390\/jcm9020436"},{"key":"9384_CR38","doi-asserted-by":"crossref","unstructured":"Gonda A et al (2020) Cellular-defined microenvironmental internalization of exosomes Extracellular Vesicles and Their Importance in Human Health, : p. 1\u201330","DOI":"10.5772\/intechopen.86020"},{"key":"9384_CR39","doi-asserted-by":"crossref","unstructured":"Gurunathan S et al (2019) Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes. 8(4):307","DOI":"10.3390\/cells8040307"},{"key":"9384_CR40","doi-asserted-by":"crossref","first-page":"686551","DOI":"10.3389\/fcell.2021.686551","volume":"9","author":"H Amini","year":"2021","unstructured":"Amini H et al (2021) An examination of the putative role of melatonin in exosome biogenesis. Front Cell Dev Biology 9:686551","journal-title":"Front Cell Dev Biology"},{"key":"9384_CR41","doi-asserted-by":"crossref","unstructured":"Frankel E, Audhya A (2018) ESCRT-dependent cargo sorting at multivesicular endosomes. In seminars in cell & developmental biology. Elsevier","DOI":"10.1016\/j.semcdb.2017.08.020"},{"key":"9384_CR42","doi-asserted-by":"crossref","unstructured":"Momen LT et al (2021) Regeneration and diagnosis of kidney Disease using Exosomes. Jentashapir J Cell Mol Biology, 12(4)","DOI":"10.5812\/jjcmb.120113"},{"key":"9384_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2017.06.003","volume":"627","author":"JX Xie","year":"2017","unstructured":"Xie JX et al (2017) MicroRNA profiling in kidney disease: plasma versus plasma-derived exosomes. Gene 627:1\u20138","journal-title":"Gene"},{"key":"9384_CR44","doi-asserted-by":"crossref","unstructured":"Stefa\u0144ska K et al (2023) The role of exosomes in Human Carcinogenesis and Cancer Therapy\u2014recent findings from Molecular and Clinical Research. 12(3):356","DOI":"10.3390\/cells12030356"},{"key":"9384_CR45","first-page":"153303381876345","volume":"17","author":"C Zhang","year":"2018","unstructured":"Zhang C et al (2018) Exosome: function and role in cancer metastasis and drug resistance. Technol Cancer Res Treat 17:1533033818763450","journal-title":"Technol Cancer Res Treat"},{"issue":"51","key":"9384_CR46","doi-asserted-by":"crossref","first-page":"2002440","DOI":"10.1002\/adma.202002440","volume":"32","author":"GH Nam","year":"2020","unstructured":"Nam GH et al (2020) Emerging prospects of exosomes for cancer treatment: from conventional therapy to immunotherapy. Adv Mater 32(51):2002440","journal-title":"Adv Mater"},{"issue":"25","key":"9384_CR47","doi-asserted-by":"crossref","first-page":"38707","DOI":"10.18632\/oncotarget.9585","volume":"7","author":"S Hiltbrunner","year":"2016","unstructured":"Hiltbrunner S et al (2016) Exosomal cancer immunotherapy is independent of MHC molecules on exosomes. Oncotarget 7(25):38707","journal-title":"Oncotarget"},{"issue":"4","key":"9384_CR48","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1172\/JCI81137","volume":"126","author":"JM Pitt","year":"2016","unstructured":"Pitt JM et al (2016) Dendritic cell\u2013derived exosomes for cancer therapy. J Clin Investig 126(4):1224\u20131232","journal-title":"J Clin Investig"},{"issue":"5","key":"9384_CR49","first-page":"1","volume":"60","author":"Y Xu","year":"2022","unstructured":"Xu Y et al (2022) Role of macrophages in tumor progression and therapy. Int J Oncol 60(5):1\u201319","journal-title":"Int J Oncol"},{"issue":"1","key":"9384_CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-021-01221-z","volume":"15","author":"MDA Paskeh","year":"2022","unstructured":"Paskeh MDA et al (2022) Emerging role of exosomes in cancer progression and tumor microenvironment remodeling. J Hematol Oncol 15(1):1\u201339","journal-title":"J Hematol Oncol"},{"key":"9384_CR51","doi-asserted-by":"crossref","unstructured":"Mantovani A et al (2022) Macrophages as tools and targets in cancer therapy : p. 1\u201322","DOI":"10.1038\/s41573-022-00520-5"},{"key":"9384_CR52","first-page":"786913","volume":"11","author":"X Ding","year":"2022","unstructured":"Ding X et al (2022) Eng Macrophages via Nanatechnol Genetic Manipulation cancer Therapy 11:786913","journal-title":"Eng Macrophages via Nanatechnol Genetic Manipulation cancer Therapy"},{"key":"9384_CR53","doi-asserted-by":"crossref","first-page":"173090","DOI":"10.1016\/j.ejphar.2020.173090","volume":"877","author":"C Yunna","year":"2020","unstructured":"Yunna C et al (2020) Macrophage M1\/M2 polarization. Eur J Pharmacol 877:173090","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"9384_CR54","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.3390\/ijms22126560","volume":"22","author":"H Wang","year":"2021","unstructured":"Wang H et al (2021) The impact of the tumor microenvironment on macrophage polarization in cancer metastatic progression. Int J Mol Sci 22(12):6560","journal-title":"Int J Mol Sci"},{"issue":"6","key":"9384_CR55","doi-asserted-by":"crossref","first-page":"R246","DOI":"10.1016\/j.cub.2020.01.031","volume":"30","author":"L Cassetta","year":"2020","unstructured":"Cassetta L, Pollard JW (2020) Tumor-associated macrophages. Curr Biol 30(6):R246\u2013R248","journal-title":"Curr Biol"},{"key":"9384_CR56","doi-asserted-by":"crossref","unstructured":"Zou Z et al (2020) mTOR signaling pathway and mTOR inhibitors in cancer: Progress and challenges. 10(1):1\u201311","DOI":"10.1186\/s13578-020-00396-1"},{"issue":"33","key":"9384_CR57","doi-asserted-by":"crossref","first-page":"eaaz0748","DOI":"10.1126\/sciadv.aaz0748","volume":"6","author":"T-T Tang","year":"2020","unstructured":"Tang T-T et al (2020) Extracellular vesicle\u2013encapsulated IL-10 as novel nanotherapeutics against ischemic AKI. Sci Adv 6(33):eaaz0748","journal-title":"Sci Adv"},{"key":"9384_CR58","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ceb.2017.02.012","volume":"45","author":"I Ben-Sahra","year":"2017","unstructured":"Ben-Sahra I, Manning BD (2017) mTORC1 signaling and the metabolic control of cell growth. Curr Opin Cell Biol 45:72\u201382","journal-title":"Curr Opin Cell Biol"},{"issue":"3","key":"9384_CR59","doi-asserted-by":"crossref","first-page":"913","DOI":"10.4049\/jimmunol.2100230","volume":"207","author":"SL Collins","year":"2021","unstructured":"Collins SL et al (2021) mTORC1 signaling regulates proinflammatory macrophage function and metabolism. J Immunol 207(3):913\u2013922","journal-title":"J Immunol"},{"key":"9384_CR60","doi-asserted-by":"crossref","first-page":"692022","DOI":"10.3389\/fimmu.2021.692022","volume":"12","author":"AA Novais","year":"2021","unstructured":"Novais AA et al (2021) Exosomes and melatonin: where their destinies intersect. Front Immunol 12:692022","journal-title":"Front Immunol"},{"key":"9384_CR61","doi-asserted-by":"crossref","unstructured":"Maleki M et al (2021) Multiple interactions between melatonin and non-coding RNAs in cancer biology, vol 98. Chemical Biology & Drug Design, pp 323\u2013340. 3","DOI":"10.1111\/cbdd.13849"},{"key":"9384_CR62","doi-asserted-by":"crossref","unstructured":"Jin C et al (2021) Exosomes: emerging therapy delivery tools and biomarkers for kidney diseases 2021","DOI":"10.1155\/2021\/7844455"},{"key":"9384_CR63","doi-asserted-by":"crossref","unstructured":"Jin C et al (2021) Exosomes: emerging therapy delivery tools and biomarkers for kidney diseases Stem cells international, 2021","DOI":"10.1155\/2021\/7844455"},{"key":"9384_CR64","doi-asserted-by":"crossref","unstructured":"Tapparo M et al (2019) Renal regenerative potential of extracellular vesicles derived from miRNA-engineered mesenchymal stromal cells. 20(10):2381","DOI":"10.3390\/ijms20102381"},{"issue":"9","key":"9384_CR65","doi-asserted-by":"crossref","first-page":"12133","DOI":"10.1021\/acsnano.0c05681","volume":"14","author":"C Zhang","year":"2020","unstructured":"Zhang C et al (2020) Supramolecular nanofibers containing arginine-glycine-aspartate (RGD) peptides boost therapeutic efficacy of extracellular vesicles in kidney repair. ACS Nano 14(9):12133\u201312147","journal-title":"ACS Nano"},{"key":"9384_CR66","doi-asserted-by":"crossref","unstructured":"Liao C et al (2022) Potential Therapeutic Effect Mech Mesenchymal stem cells-extracellular Vesicles Ren Fibros 10","DOI":"10.3389\/fcell.2022.824752"},{"key":"9384_CR67","doi-asserted-by":"crossref","unstructured":"Zhang W et al (2018) MicroRNAs in serum exosomes as potential biomarkers in clear-cell renal cell carcinoma. 4(3):412\u2013419","DOI":"10.1016\/j.euf.2016.09.007"},{"issue":"17","key":"9384_CR68","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2174\/1381612826666200318153106","volume":"26","author":"P Fang","year":"2020","unstructured":"Fang P et al (2020) Targeting strategies for renal cancer stem cell therapy. Curr Pharm Design 26(17):1964\u20131978","journal-title":"Curr Pharm Design"},{"key":"9384_CR69","doi-asserted-by":"crossref","unstructured":"He X et al (2022) Circulating exosomal mRNA signatures for the early diagnosis of clear cell renal cell carcinoma. 20(1):1\u201313","DOI":"10.1186\/s12916-022-02467-1"},{"issue":"5","key":"9384_CR70","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3390\/diagnostics10050311","volume":"10","author":"IO Sun","year":"2020","unstructured":"Sun IO, Lerman LO (2020) Urinary extracellular vesicles as biomarkers of kidney disease: from diagnostics to therapeutics. Diagnostics 10(5):311","journal-title":"Diagnostics"},{"issue":"3","key":"9384_CR71","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.trecan.2019.02.003","volume":"5","author":"N Chatterjee","year":"2019","unstructured":"Chatterjee N, Bivona TG (2019) Polytherapy and targeted cancer drug resistance. Trends cancer 5(3):170\u2013182","journal-title":"Trends cancer"},{"issue":"4","key":"9384_CR72","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1530\/REP-22-0338","volume":"165","author":"S Barton","year":"2023","unstructured":"Barton S et al (2023) miR-23b-3p regulates human endometrial epithelial cell adhesion implying a role in implantation. Reproduction 165(4):407\u2013416","journal-title":"Reproduction"},{"key":"9384_CR73","doi-asserted-by":"crossref","unstructured":"Guo Y-X et al (2021) The role of miR-23b in cancer and autoimmune disease Journal of Oncology, 2021","DOI":"10.1155\/2021\/6473038"},{"key":"9384_CR74","doi-asserted-by":"crossref","unstructured":"Xu N et al (2022) Exosomes-mediated tumor treatment: one body plays multiple roles. 17(3):385\u2013400","DOI":"10.1016\/j.ajps.2021.08.003"},{"issue":"1","key":"9384_CR75","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3892\/ijo.2015.2993","volume":"36","author":"Y Zhang","year":"2010","unstructured":"Zhang Y et al (2010) Exosomes derived from IL-12-anchored renal cancer cells increase induction of specific antitumor response in vitro: a novel vaccine for renal cell carcinoma. Int J Oncol 36(1):133\u2013140","journal-title":"Int J Oncol"},{"key":"9384_CR76","doi-asserted-by":"crossref","unstructured":"Shi L et al (2021) MicroRNAs in body fluids: a more promising biomarker for clear cell renal cell carcinoma. Cancer Manage Res, : p. 7663\u20137675","DOI":"10.2147\/CMAR.S330881"},{"issue":"18","key":"9384_CR77","doi-asserted-by":"crossref","first-page":"14356","DOI":"10.3390\/ijms241814356","volume":"24","author":"S Boussios","year":"2023","unstructured":"Boussios S et al (2023) Exosomes in the diagnosis and treatment of renal cell Cancer. Int J Mol Sci 24(18):14356","journal-title":"Int J Mol Sci"},{"key":"9384_CR78","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.cca.2019.10.022","volume":"500","author":"I-M Chung","year":"2020","unstructured":"Chung I-M et al (2020) Exosomes: current use and future applications. Clin Chim Acta 500:226\u2013232","journal-title":"Clin Chim Acta"},{"issue":"2","key":"9384_CR79","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/jhg.2014.111","volume":"60","author":"H Mataki","year":"2015","unstructured":"Mataki H et al (2015) Downregulation of the microRNA-1\/133a cluster enhances cancer cell migration and invasion in lung-squamous cell carcinoma via regulation of Coronin1C. J Hum Genet 60(2):53\u201361","journal-title":"J Hum Genet"},{"issue":"6","key":"9384_CR80","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s10735-013-9516-5","volume":"44","author":"Z Yu","year":"2013","unstructured":"Yu Z et al (2013) Identification of miR-7 as an oncogene in renal cell carcinoma. J Mol Histol 44(6):669\u2013677","journal-title":"J Mol Histol"},{"issue":"3","key":"9384_CR81","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/15384101.2018.1475826","volume":"18","author":"L Liu","year":"2019","unstructured":"Liu L et al (2019) Long non-coding RNA GAS5 sensitizes renal cell carcinoma to sorafenib via miR-21\/SOX5 pathway. Cell Cycle 18(3):257\u2013263","journal-title":"Cell Cycle"},{"key":"9384_CR82","doi-asserted-by":"crossref","first-page":"115","DOI":"10.32471\/exp-oncology.2312-8852.vol-42-no-2.14632","volume":"42","author":"K Onyshchenko","year":"2020","unstructured":"Onyshchenko K et al (2020) Expression of micro-RNA hsa-miR-30c-5p and hsa-mir-138-1 in renal cell carcinoma. Exp Oncol 42:115\u2013119","journal-title":"Exp Oncol"},{"issue":"2","key":"9384_CR83","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/2211-5463.13025","volume":"11","author":"L Liang","year":"2021","unstructured":"Liang L et al (2021) Retracted: miR-30d\u20105p suppresses proliferation and autophagy by targeting ATG5 in renal cell carcinoma. FEBS open bio 11(2):529\u2013540","journal-title":"FEBS open bio"},{"key":"9384_CR84","doi-asserted-by":"crossref","unstructured":"Zeng J et al (2020) lncRNA 00312 attenuates cell proliferation and invasion and promotes apoptosis in renal cell carcinoma via miR-34a-5p\/ASS1 axis Oxidative medicine and cellular longevity, 2020","DOI":"10.1155\/2020\/5737289"},{"key":"9384_CR85","doi-asserted-by":"crossref","unstructured":"Toraih EA et al (2017) MicroRNA-34a: a key regulator in the hallmarks of renal cell carcinoma Oxidative Medicine and Cellular Longevity, 2017","DOI":"10.1155\/2017\/3269379"},{"issue":"5","key":"9384_CR86","first-page":"1759","volume":"54","author":"Y Osako","year":"2019","unstructured":"Osako Y et al (2019) Potential tumor\u2013suppressive role of microRNA\u201399a\u20133p in sunitinib\u2013resistant renal cell carcinoma cells through the regulation of RRM2. Int J Oncol 54(5):1759\u20131770","journal-title":"Int J Oncol"},{"issue":"3","key":"9384_CR87","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.bbrc.2019.01.116","volume":"510","author":"K Sun","year":"2019","unstructured":"Sun K et al (2019) Long non-coding RNA XIST regulates miR-106b-5p\/P21 axis to suppress tumor progression in renal cell carcinoma. Biochem Biophys Res Commun 510(3):416\u2013420","journal-title":"Biochem Biophys Res Commun"},{"key":"9384_CR88","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.2147\/OTT.S184674","volume":"12","author":"L-J Miao","year":"2019","unstructured":"Miao L-J et al (2019) miR-106b promotes proliferation and invasion by targeting Capicua through MAPK signaling in renal carcinoma cancer. OncoTargets Therapy 12:3595","journal-title":"OncoTargets Therapy"},{"issue":"1","key":"9384_CR89","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3892\/mmr.2020.11125","volume":"22","author":"Y Xu","year":"2020","unstructured":"Xu Y et al (2020) miR\u2013133b affects cell proliferation, invasion and chemosensitivity in renal cell carcinoma by inhibiting the ERK signaling pathway. Mol Med Rep 22(1):67\u201376","journal-title":"Mol Med Rep"},{"key":"9384_CR90","doi-asserted-by":"crossref","first-page":"104452","DOI":"10.1016\/j.cellimm.2021.104452","volume":"371","author":"C Yan","year":"2022","unstructured":"Yan C et al (2022) MiR-1294 suppresses ROS-dependent inflammatory response in atopic dermatitis via restraining STAT3\/NF-\u03baB pathway. Cell Immunol 371:104452","journal-title":"Cell Immunol"},{"issue":"1","key":"9384_CR91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-022-02574-0","volume":"42","author":"S Liu","year":"2023","unstructured":"Liu S et al (2023) HES1-mediated down-regulation of miR-138 sustains NOTCH1 activation and promotes proliferation and invasion in renal cell carcinoma. J Experimental Clin Cancer Res 42(1):1\u201315","journal-title":"J Experimental Clin Cancer Res"},{"issue":"8","key":"9384_CR92","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41419-020-02877-0","volume":"11","author":"P Dasgupta","year":"2020","unstructured":"Dasgupta P et al (2020) LncRNA CDKN2B-AS1\/miR-141\/cyclin D network regulates tumor progression and metastasis of renal cell carcinoma. Cell Death Dis 11(8):660","journal-title":"Cell Death Dis"},{"issue":"7","key":"9384_CR93","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41419-021-03958-4","volume":"12","author":"J Wang","year":"2021","unstructured":"Wang J et al (2021) SNP-mediated lncRNA-ENTPD3-AS1 upregulation suppresses renal cell carcinoma via miR-155\/HIF-1\u03b1 signaling. Cell Death Dis 12(7):672","journal-title":"Cell Death Dis"},{"issue":"2","key":"9384_CR94","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/jcb.27347","volume":"120","author":"X Wang","year":"2019","unstructured":"Wang X et al (2019) Serum exosomal miR-210 as a potential biomarker for clear cell renal cell carcinoma. J Cell Biochem 120(2):1492\u20131502","journal-title":"J Cell Biochem"},{"issue":"61","key":"9384_CR95","doi-asserted-by":"crossref","first-page":"103315","DOI":"10.18632\/oncotarget.21733","volume":"8","author":"F Dias","year":"2017","unstructured":"Dias F et al (2017) Plasmatic miR-210, miR-221 and miR-1233 profile: potential liquid biopsies candidates for renal cell carcinoma. Oncotarget 8(61):103315","journal-title":"Oncotarget"},{"key":"9384_CR96","doi-asserted-by":"crossref","unstructured":"Toraih EA et al (2022) Applications of noncoding RNAs in renal cancer patients, in clinical applications of non-coding RNAs in Cancer. Elsevier, pp 211\u2013284","DOI":"10.1016\/B978-0-12-824550-7.00003-5"},{"issue":"3","key":"9384_CR97","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/dna.2022.0557","volume":"42","author":"Z Wang","year":"2023","unstructured":"Wang Z, Xie W, Guan H (2023) Diverse functions of MiR-425 in Human Cancer. DNA Cell Biol 42(3):113\u2013129","journal-title":"DNA Cell Biol"},{"issue":"4","key":"9384_CR98","first-page":"2181","volume":"11","author":"G Jia","year":"2019","unstructured":"Jia G et al (2019) Mir-590-5p promotes liver cancer growth and chemotherapy resistance through directly targeting FOXO1. Am J Translational Res 11(4):2181","journal-title":"Am J Translational Res"},{"issue":"4","key":"9384_CR99","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10863-021-09901-8","volume":"53","author":"L Cheng","year":"2021","unstructured":"Cheng L et al (2021) Circ_RPL23A acts as a miR-1233 sponge to suppress the progression of clear cell renal cell carcinoma by promoting ACAT2. J Bioenerg Biomembr 53(4):415\u2013428","journal-title":"J Bioenerg Biomembr"},{"issue":"3","key":"9384_CR100","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/jcb.30191","volume":"123","author":"MR Kalhori","year":"2022","unstructured":"Kalhori MR et al (2022) The potential role of miR-1290 in cancer progression, diagnosis, prognosis, and treatment: an oncomiR or onco\u2010suppressor microRNA? J Cell Biochem 123(3):506\u2013531","journal-title":"J Cell Biochem"},{"issue":"1","key":"9384_CR101","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/s12882-023-03438-1","volume":"24","author":"O Anbiyaee","year":"2023","unstructured":"Anbiyaee O et al (2023) The functions of long non-coding RNA (lncRNA)-MALAT-1 in the pathogenesis of renal cell carcinoma. BMC Nephrol 24(1):380","journal-title":"BMC Nephrol"},{"issue":"1","key":"9384_CR102","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3390\/genes15010123","volume":"15","author":"LA Bravo-V\u00e1zquez","year":"2024","unstructured":"Bravo-V\u00e1zquez LA et al (2024) Exploring the therapeutic significance of microRNAs and lncRNAs in kidney diseases. Genes 15(1):123","journal-title":"Genes"},{"issue":"25","key":"9384_CR103","doi-asserted-by":"crossref","first-page":"2207549","DOI":"10.1002\/advs.202207549","volume":"10","author":"W Zhou","year":"2023","unstructured":"Zhou W et al (2023) Yin Yang 1-Induced Long Noncoding RNA DUXAP9 drives the progression of oral squamous cell carcinoma by blocking CDK1\u2010Mediated EZH2 degradation. Adv Sci 10(25):2207549","journal-title":"Adv Sci"},{"issue":"6","key":"9384_CR104","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1158\/0008-5472.CAN-20-0832","volume":"81","author":"P Kulkarni","year":"2021","unstructured":"Kulkarni P et al (2021) A lncRNA TCL6-miR-155 interaction regulates the src-Akt-EMT network to mediate kidney cancer progression and metastasis. Cancer Res 81(6):1500\u20131512","journal-title":"Cancer Res"},{"key":"9384_CR105","doi-asserted-by":"crossref","first-page":"777507","DOI":"10.3389\/fmed.2021.777507","volume":"8","author":"T Li","year":"2022","unstructured":"Li T et al (2022) Identification of a three-glycolysis-related lncRNA signature correlated with prognosis and metastasis in clear cell renal cell carcinoma. Front Med 8:777507","journal-title":"Front Med"},{"issue":"1","key":"9384_CR106","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12935-023-03173-5","volume":"23","author":"P Xu","year":"2023","unstructured":"Xu P et al (2023) LncRNA AGAP2 antisense RNA 1 stabilized by insulin-like growth factor 2 mRNA binding protein 3 promotes macrophage M2 polarization in clear cell renal cell carcinoma through regulation of the microRNA-9-5p\/THBS2\/PI3K-Akt pathway. Cancer Cell Int 23(1):330","journal-title":"Cancer Cell Int"},{"key":"9384_CR107","doi-asserted-by":"crossref","unstructured":"Fu S et al (2021) Prognostic value of long noncoding RNA DLEU2 and its relationship with immune infiltration in kidney renal clear cell carcinoma and liver hepatocellular carcinoma. Int J Gen Med, : p. 8047\u20138064","DOI":"10.2147\/IJGM.S336428"},{"issue":"9","key":"9384_CR108","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.7150\/jca.73758","volume":"13","author":"F-J Zhou","year":"2022","unstructured":"Zhou F-J et al (2022) LncRNA LINC00460 facilitates the proliferation and metastasis of renal cell carcinoma via PI3K\/AKT signaling pathway. J Cancer 13(9):2844","journal-title":"J Cancer"},{"issue":"12","key":"9384_CR109","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1016\/j.ajpath.2019.06.016","volume":"189","author":"D Zhang","year":"2019","unstructured":"Zhang D et al (2019) Down-regulation of circular RNA_000926 attenuates renal cell carcinoma progression through miRNA-411\u2013dependent CDH2 inhibition. Am J Pathol 189(12):2469\u20132486","journal-title":"Am J Pathol"},{"key":"9384_CR110","doi-asserted-by":"crossref","unstructured":"Luo S et al (2022) Circ_0005875 sponges miR-502-5p to promote renal cell carcinoma progression through upregulating E26 transformation specific-1 Anti-cancer drugs. 33(1):e286\u2013e298","DOI":"10.1097\/CAD.0000000000001205"},{"issue":"11","key":"9384_CR111","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/s41419-021-04366-4","volume":"12","author":"L-J Gong","year":"2021","unstructured":"Gong L-J et al (2021) CircESRP1 inhibits clear cell renal cell carcinoma progression through the CTCF-mediated positive feedback loop. Cell Death Dis 12(11):1081","journal-title":"Cell Death Dis"},{"key":"9384_CR112","doi-asserted-by":"crossref","unstructured":"Fang L, Ye T, An Y (2021) Circular RNA FOXP1 induced by ZNF263 upregulates U2AF2 expression to accelerate renal cell carcinoma tumorigenesis and warburg effect through Sponging miR-423-5p Journal of Immunology Research, 2021","DOI":"10.1155\/2021\/8050993"},{"key":"9384_CR113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-020-01429-x","volume":"20","author":"W Li","year":"2021","unstructured":"Li W et al (2021) Revealing potential lipid biomarkers in clear cell renal cell carcinoma using targeted quantitative lipidomics. Lipids Health Dis 20:1\u201313","journal-title":"Lipids Health Dis"},{"key":"9384_CR114","doi-asserted-by":"crossref","unstructured":"Xu Z et al (2023) Identify AGAP2 as prognostic biomarker in clear cell renal cell carcinoma based on bioinformatics and IHC staining. Heliyon, 9(2)","DOI":"10.1016\/j.heliyon.2023.e13543"},{"key":"9384_CR115","doi-asserted-by":"crossref","unstructured":"Song Q et al (2022) Exosomes in urological diseases-biological functions and clinical applications. Cancer Lett, : p. 215809","DOI":"10.1016\/j.canlet.2022.215809"},{"key":"9384_CR116","doi-asserted-by":"crossref","unstructured":"Song Q et al (2022) Exosomes in urological diseases-Biological functions and clinical applications : p. 215809","DOI":"10.1016\/j.canlet.2022.215809"},{"key":"9384_CR117","doi-asserted-by":"crossref","first-page":"s45","DOI":"10.1590\/1806-9282.66.s1.45","volume":"66","author":"C S\u00e1vio-Silva","year":"2020","unstructured":"S\u00e1vio-Silva C et al (2020) Mesenchymal stem cell therapy in acute kidney injury (AKI): review and perspectives. Revista Da Associa\u00e7\u00e3o M\u00e9dica Brasileira 66:s45\u2013s54","journal-title":"Revista Da Associa\u00e7\u00e3o M\u00e9dica Brasileira"},{"issue":"3","key":"9384_CR118","doi-asserted-by":"crossref","first-page":"e12632","DOI":"10.1111\/jpi.12632","volume":"68","author":"YM Yoon","year":"2020","unstructured":"Yoon YM et al (2020) Melatonin-stimulated exosomes enhance the regenerative potential of chronic kidney disease\u2010derived mesenchymal stem\/stromal cells via cellular prion proteins. J Pineal Res 68(3):e12632","journal-title":"J Pineal Res"},{"key":"9384_CR119","doi-asserted-by":"crossref","unstructured":"Yoon YM et al (2020) Melatonin-stimulated exosomes enhance the regenerative potential of chronic kidney disease\u2010derived mesenchymal stem\/stromal cells via cellular prion proteins 68(3): p. e12632","DOI":"10.1111\/jpi.12632"},{"issue":"12","key":"9384_CR120","doi-asserted-by":"crossref","first-page":"6596","DOI":"10.3390\/ijms22126596","volume":"22","author":"L Birtwistle","year":"2021","unstructured":"Birtwistle L, Chen X-M, Pollock C (2021) Mesenchymal stem cell-derived extracellular vesicles to the rescue of renal injury. Int J Mol Sci 22(12):6596","journal-title":"Int J Mol Sci"},{"key":"9384_CR121","doi-asserted-by":"crossref","unstructured":"Gao L et al (2020) Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury-chronic kidney disease progression. 5(1):9","DOI":"10.1038\/s41392-020-0106-1"},{"key":"9384_CR122","doi-asserted-by":"crossref","first-page":"631703","DOI":"10.3389\/fonc.2021.631703","volume":"11","author":"T Su","year":"2021","unstructured":"Su T et al (2021) Exosomal MicroRNAs mediating crosstalk between cancer cells with cancer-associated fibroblasts and tumor-associated macrophages in the tumor microenvironment. Front Oncol 11:631703","journal-title":"Front Oncol"},{"key":"9384_CR123","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00011-020-01318-0","volume":"69","author":"MS Baig","year":"2020","unstructured":"Baig MS et al (2020) Tumor-derived exosomes in the regulation of macrophage polarization. Inflamm Res 69:435\u2013451","journal-title":"Inflamm Res"},{"issue":"8","key":"9384_CR124","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1111\/cas.14494","volume":"111","author":"Wl Zhang","year":"2020","unstructured":"Zhang Wl et al (2020) Extracellular vesicle long non\u2013coding RNA-mediated crosstalk in the tumor microenvironment: tiny molecules, huge roles. Cancer Sci 111(8):2726\u20132735","journal-title":"Cancer Sci"},{"key":"9384_CR125","doi-asserted-by":"crossref","unstructured":"Zhang W et al (2022) Renal cell carcinoma-derived exosomes deliver lncARSR to induce macrophage polarization and promote tumor progression via STAT3 pathway. 18(8):3209\u20133222","DOI":"10.7150\/ijbs.70289"},{"issue":"6","key":"9384_CR126","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3390\/biomedicines10061287","volume":"10","author":"M Monti","year":"2022","unstructured":"Monti M et al (2022) Micro-RNAs predict response to systemic treatments in metastatic renal cell carcinoma patients: results from a systematic review of the literature. Biomedicines 10(6):1287","journal-title":"Biomedicines"},{"key":"9384_CR127","doi-asserted-by":"crossref","unstructured":"Peng J et al (2015) let-7b and let-7c are determinants of intrinsic chemoresistance in renal cell carcinoma. 13:1\u20138","DOI":"10.1186\/s12957-015-0596-4"},{"issue":"38","key":"9384_CR128","doi-asserted-by":"crossref","first-page":"63703","DOI":"10.18632\/oncotarget.19476","volume":"8","author":"M Du","year":"2017","unstructured":"Du M et al (2017) Plasma exosomal miRNAs-based prognosis in metastatic kidney cancer. Oncotarget 8(38):63703","journal-title":"Oncotarget"},{"key":"9384_CR129","doi-asserted-by":"crossref","unstructured":"Srivastava A et al (2018) Exosome RNAs as biomarkers and targets for cancer therapy. Diagnostic and therapeutic applications of exosomes in cancer. Elsevier, pp 129\u2013159","DOI":"10.1016\/B978-0-12-812774-2.00008-0"},{"issue":"16","key":"9384_CR130","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.3390\/ijms21165840","volume":"21","author":"W Olejarz","year":"2020","unstructured":"Olejarz W et al (2020) Exosomes in angiogenesis and anti-angiogenic therapy in cancers. Int J Mol Sci 21(16):5840","journal-title":"Int J Mol Sci"},{"issue":"25","key":"9384_CR131","first-page":"3748","volume":"124","author":"T Umezu","year":"2014","unstructured":"Umezu T et al (2014) Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1 blood. J Am Soc Hematol 124(25):3748\u20133757","journal-title":"J Am Soc Hematol"},{"key":"9384_CR132","doi-asserted-by":"crossref","unstructured":"Olejarz W et al (2020) Exosomes in angiogenesis and anti-angiogenic therapy in cancers. 21(16):5840","DOI":"10.3390\/ijms21165840"},{"issue":"4","key":"9384_CR133","doi-asserted-by":"crossref","first-page":"490","DOI":"10.34172\/apb.2020.061","volume":"10","author":"M Jahani","year":"2020","unstructured":"Jahani M et al (2020) Regenerative medicine and angiogenesis; challenges and opportunities. Adv Pharm Bull 10(4):490","journal-title":"Adv Pharm Bull"},{"key":"9384_CR134","doi-asserted-by":"crossref","unstructured":"Long C et al (2023) Therapeutic potential of exosomes from adipose-derived stem cells in chronic wound healing Application of Stem Cell Therapy and Bioinformatics in Wound Repair and Skin Diseases. 16648714:118","DOI":"10.3389\/fsurg.2022.1030288"},{"key":"9384_CR135","doi-asserted-by":"crossref","unstructured":"Jahani M et al (2020) Regenerative medicine and angiogenesis; challenges and opportunities. 10(4):490","DOI":"10.34172\/apb.2020.061"},{"issue":"17","key":"9384_CR136","doi-asserted-by":"crossref","first-page":"9543","DOI":"10.3390\/ijms22179543","volume":"22","author":"N Ku\u010duk","year":"2021","unstructured":"Ku\u010duk N et al (2021) Exosomes engineering and their roles as therapy delivery tools, therapeutic targets, and biomarkers. Int J Mol Sci 22(17):9543","journal-title":"Int J Mol Sci"},{"key":"9384_CR137","first-page":"34","volume":"10","author":"L Chen","year":"2022","unstructured":"Chen L et al (2022) Exosomes as drug carriers in anti-cancer therapy. Front Cell Dev Biology 10:34","journal-title":"Front Cell Dev Biology"},{"key":"9384_CR138","doi-asserted-by":"crossref","first-page":"811971","DOI":"10.3389\/fbioe.2021.811971","volume":"9","author":"J Chen","year":"2022","unstructured":"Chen J et al (2022) Review on strategies and technologies for exosome isolation and purification. Front Bioeng Biotechnol 9:811971","journal-title":"Front Bioeng Biotechnol"},{"issue":"11","key":"9384_CR139","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1039\/C5LC00240K","volume":"15","author":"A Liga","year":"2015","unstructured":"Liga A et al (2015) Exosome isolation: a microfluidic road-map. Lab Chip 15(11):2388\u20132394","journal-title":"Lab Chip"},{"key":"9384_CR140","doi-asserted-by":"crossref","unstructured":"Xu M et al (2020) Recent advancements in the loading and modification of therapeutic exosomes. 8:586130","DOI":"10.3389\/fbioe.2020.586130"},{"key":"9384_CR141","doi-asserted-by":"crossref","first-page":"112050","DOI":"10.1016\/j.biopha.2021.112050","volume":"142","author":"S Ghafouri-Fard","year":"2021","unstructured":"Ghafouri-Fard S et al (2021) The impact of non-coding RNAs on normal stem cells. Biomed Pharmacother 142:112050","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"9384_CR142","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s13770-021-00361-0","volume":"18","author":"H Choi","year":"2021","unstructured":"Choi H et al (2021) Biodistribution of exosomes and engineering strategies for targeted delivery of therapeutic exosomes. Tissue Eng Regenerative Med 18(4):499\u2013511","journal-title":"Tissue Eng Regenerative Med"},{"key":"9384_CR143","doi-asserted-by":"crossref","unstructured":"Faruqu FN, Xu L, Al-Jamal KT (2018) Preparation of exosomes for siRNA delivery to cancer cells. JoVE (Journal Visualized Experiments), (142): p. e58814","DOI":"10.3791\/58814"},{"key":"9384_CR144","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s40259-020-00434-x","volume":"34","author":"D Jafari","year":"2020","unstructured":"Jafari D et al (2020) Designer exosomes: a new platform for biotechnology therapeutics. BioDrugs 34:567\u2013586","journal-title":"BioDrugs"},{"key":"9384_CR145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12896-021-00683-w","volume":"21","author":"C Aslan","year":"2021","unstructured":"Aslan C et al (2021) Exosomes for mRNA delivery: a novel biotherapeutic strategy with hurdles and hope. BMC Biotechnol 21:1\u201312","journal-title":"BMC Biotechnol"},{"issue":"1","key":"9384_CR146","doi-asserted-by":"crossref","first-page":"12277","DOI":"10.1038\/ncomms12277","volume":"7","author":"N Yim","year":"2016","unstructured":"Yim N et al (2016) Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein\u2013protein interaction module. Nat Commun 7(1):12277","journal-title":"Nat Commun"},{"key":"9384_CR147","doi-asserted-by":"crossref","unstructured":"Hadizadeh N et al (2022) Extracellular vesicles biogenesis, isolation, manipulation and genetic engineering for potential in vitro and in vivo therapeutics: an overview. Front Bioeng Biotechnol, 10","DOI":"10.3389\/fbioe.2022.1019821"},{"issue":"1","key":"9384_CR148","first-page":"3","volume":"2","author":"J Kim","year":"2021","unstructured":"Kim J et al (2021) Platform technologies and human cell lines for the production of therapeutic exosomes. Extracell Vesicles Circulating Nucleic Acids 2(1):3\u201317","journal-title":"Extracell Vesicles Circulating Nucleic Acids"},{"key":"9384_CR149","doi-asserted-by":"crossref","unstructured":"Uddin N et al (2022) Targeted delivery of RNAi to cancer cells using RNA-ligand displaying exosome. Acta Pharm Sinica B","DOI":"10.1016\/j.apsb.2022.11.019"},{"issue":"10","key":"9384_CR150","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1021\/bc500291r","volume":"25","author":"T Smyth","year":"2014","unstructured":"Smyth T et al (2014) Surface functionalization of exosomes using click chemistry. Bioconjug Chem 25(10):1777\u20131784","journal-title":"Bioconjug Chem"},{"issue":"34","key":"9384_CR151","doi-asserted-by":"crossref","first-page":"1802052","DOI":"10.1002\/smll.201802052","volume":"14","author":"S Kumar","year":"2018","unstructured":"Kumar S et al (2018) Cloaked exosomes: biocompatible, durable, and degradable encapsulation. Small 14(34):1802052","journal-title":"Small"},{"issue":"5","key":"9384_CR152","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/anie.201912524","volume":"59","author":"W Nie","year":"2020","unstructured":"Nie W et al (2020) Responsive exosome nano-bioconjugates for synergistic cancer therapy. Angew Chem Int Ed 59(5):2018\u20132022","journal-title":"Angew Chem Int Ed"},{"key":"9384_CR153","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1007\/s10616-016-9952-7","volume":"68","author":"KB Johnsen","year":"2016","unstructured":"Johnsen KB et al (2016) Evaluation of electroporation-induced adverse effects on adipose-derived stem cell exosomes. Cytotechnology 68:2125\u20132138","journal-title":"Cytotechnology"},{"key":"9384_CR154","doi-asserted-by":"crossref","unstructured":"Kim MS et al (2016) Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells Nanomedicine: Nanotechnology, Biology and Medicine, 12(3): p. 655\u2013664","DOI":"10.1016\/j.nano.2015.10.012"},{"issue":"3","key":"9384_CR155","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3390\/nano13030387","volume":"13","author":"KT Pammi Guru","year":"2023","unstructured":"Pammi Guru KT, Praween N, Basu PK (2023) Isolation of exosomes from human serum using gold-nanoparticle-coated Silicon Surface. Nanomaterials 13(3):387","journal-title":"Nanomaterials"},{"key":"9384_CR156","doi-asserted-by":"crossref","unstructured":"Chen H et al (2021) Exosomes, a new star for targeted delivery. Front Cell Dev Biology, : p. 2827","DOI":"10.3389\/fcell.2021.751079"},{"key":"9384_CR157","first-page":"103","volume":"74","author":"TL Whiteside","year":"2016","unstructured":"Whiteside TL (2016) J.A.i.c.c. Tumor-derived Exosomes Their role cancer Progression 74:103\u2013141","journal-title":"Tumor-derived Exosomes Their role cancer Progression"},{"issue":"8","key":"9384_CR158","first-page":"875","volume":"15","author":"W Mu","year":"2013","unstructured":"Mu W, Rana S, Z\u00f6ller MJN (2013) Host Matrix Modulation Tumor Exosomes Promotes Motil Invasiveness 15(8):875\u2013IN4","journal-title":"Host Matrix Modulation Tumor Exosomes Promotes Motil Invasiveness"},{"key":"9384_CR159","doi-asserted-by":"crossref","unstructured":"Lokody IJNRC (2014) Exosomally derived miR-105 destroys tight junctions. 14(6):386\u2013387","DOI":"10.1038\/nrc3747"},{"key":"9384_CR160","doi-asserted-by":"crossref","unstructured":"Zhou W et al (2014) Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. 25(4):501\u2013515","DOI":"10.1016\/j.ccr.2014.03.007"},{"issue":"2","key":"9384_CR161","first-page":"455","volume":"1871","author":"L Zhang","year":"2019","unstructured":"Zhang L (2019) D.J.B.e.B.A.-R.o.C. Yu. Exosomes cancer Dev Metastasis Immun 1871(2):455\u2013468","journal-title":"Exosomes cancer Dev Metastasis Immun"},{"issue":"2","key":"9384_CR162","first-page":"171","volume":"7","author":"C-H Wong","year":"2019","unstructured":"Wong C-H (2019) And Y.-C.J.W.j.o.c.c. Chen. Clin Significance Exosomes as Potential Biomarkers cancer 7(2):171","journal-title":"Clin Significance Exosomes as Potential Biomarkers cancer"},{"issue":"4","key":"9384_CR163","first-page":"387","volume":"20","author":"A Makler","year":"2020","unstructured":"Makler A (2020) W.J.E.r.o.m.d. Asghar. Exosomal Biomarkers cancer Diagnosis Patient Monit 20(4):387\u2013400","journal-title":"Exosomal Biomarkers cancer Diagnosis Patient Monit"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09384-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-024-09384-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-024-09384-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T20:59:22Z","timestamp":1738702762000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-024-09384-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,23]]},"references-count":163,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9384"],"URL":"https:\/\/doi.org\/10.1007\/s11033-024-09384-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,23]]},"assertion":[{"value":"14 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the research deputy of Kermanshah University of Medical Sciences, Kermanshah, Iran (Ethics approval ID: IR.KUMS.REC.1401.253).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"443"}}